Catalyst Pharmaceutical
CPRX
CPRX
313 hedge funds and large institutions have $1.89B invested in Catalyst Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 97 increasing their positions, 105 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
313
Holders Change
+42
Holders Change %
+15.5%
% of All Funds
4.53%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
65
Increased
97
Reduced
105
Closed
22
Calls
$610K
Puts
$1.58M
Net Calls
-$970K
Net Calls Change
-$703K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$36.2M |
| 2 |
2
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$13.3M |
| 3 |
3
Millennium Management
New York
|
$11.1M |
| 4 |
4
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
$8.35M |
| 5 |
5
Goldman Sachs
New York
|
$29.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EFM
326
E Fund Management
Guangzhou,
China
| – | -$175K | -11,266 | Closed |
|
327
Wolverine Trading
Chicago,
Illinois
| – | -$164K | -10,609 | Closed |
|
328
Daiwa Securities Group
Tokyo,
Japan
| – | -$158K | -10,200 | Closed |
|
|
PAS
329
Point72 Asia (Singapore)
Singapore
| – | -$153K | -9,857 | Closed |
|
|
CSS
330
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$132K | -8,523 | Closed |
|
|
NVCHI
331
New Vernon Capital Holdings II
Morristown,
New Jersey
| – | -$122K | -7,864 | Closed |
|
|
IC
332
Innealta Capital
Austin,
Texas
| – | -$2.51K | -162 | Closed |
|
|
NA
333
NewEdge Advisors
New Orleans,
Louisiana
| – | -$1.08K | -70 | Closed |
|
|
APC
334
Aspire Private Capital
Cornelius,
North Carolina
| – | -$310 | -20 | Closed |
|